Management of Optic Neuritis
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Exploring Risvidetinib in Phase 2 Trial for Untreated Parkinson Disease: Milton Werner, PhD
2
FDA Adds Boxed Warning, Narrows Indication for DMD Gene Therapy
3
Using Machine Learning for Risk Prediction in Multiple Sclerosis Following DMT Discontinuation: Marisa McGinley, DO
4
BBP-418 Success in LGMD, Alixorexton Improves Narcolepsy Symptoms, Fenebrutinib Meets Phase 3 End Points
5
